WEBULL
WebtradeDownload

JBT Marel (JBTM) Could Be 37% Undervalued After Softer Quarterly Results

Simply Wall St · 2d ago

Recent softer quarterly results at JBT Marel (JBTM) and a declining return on invested capital have turned a spotlight on how effectively the business is deploying fresh capital into new projects.

Over the past year, JBT Marel’s share price has retreated, with a 30-day share price return down 4.89% and the year-to-date share price return down 29.66%. However, the 3-year total shareholder return of 7.80% shows that longer term momentum has been much steadier than the recent pullback suggests.

Scan beyond JBT Marel and compare it with a handpicked 33 high quality undervalued stocks that also pairs solid fundamentals with potential mispricing.

For JBT Marel, the recent slide could be read as a verdict on weakening project returns or as sentiment overshooting short term worries. The valuation now has to show which story fits.

Most Popular Narrative: 36.6% Undervalued

Against a last close of $105.93, the most followed narrative places JBT Marel’s fair value at $167.06, framing the recent share price pullback as a gap between current sentiment and modeled long term cash generation, using a 9.08% discount rate.

The ongoing global increase in protein consumption and demand for food safety/traceability is driving sustained investment in automation and integrated processing solutions. This is supporting a robust order backlog (notably in poultry and meat), which is likely to provide multi-year revenue growth.

See why 3 investors see JBT Marel as 37% undervalued.

The same narrative links that valuation to specific building blocks. It uses revenue rising from $3,926.2m today to $4.4b by 2029, profit margins moving from 4.9% to 13.1%, and earnings reaching $581.5m. It then discounts those cash flows at 9.08% and applies a P/E of 18.9x on those future earnings.

Analysts included in this view are not aligned on outcomes, with price targets ranging from $118.0 to $210.0. That spread underlines how much of the 36.6% implied undervaluation rests on successful merger integration, margin improvement and execution against the order pipeline in protein and prepared foods.

At the current share price, the narrative implies a sizeable margin of safety relative to its $167.06 fair value output. It also flags that tariff risk, integration complexity, supply chain adjustments and the quality of earnings, including one off items, are crucial swing factors for that thesis.

Result: Fair Value of $167.06 (UNDERVALUED)

Still, the story around JBT Marel only holds if the merger integration delivers and tariff or supply chain setbacks do not erode the modeled margin recovery.

Find out about the key risks to this JBT Marel narrative.

Next Steps

Mixed signals on JBT Marel so far, with both pressure points and bright spots, mean you are better off testing the numbers yourself and deciding quickly where you stand by weighing its 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond JBT Marel?

If you stop with JBT Marel, you risk missing other opportunities that line up better with your goals, time horizon and appetite for risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.